Latest Health News

3D Energi Limited remains suspended from ASX trading after failing to provide a crucial update on its funding status and exploration permit implications, prolonging market uncertainty.

GR Engineering Services reports a solid half-year performance with $218 million revenue and a raised interim dividend, underscoring confidence amid softer top-line results.

Cobram Estate Olives reported a widened half-year loss driven by higher oil costs and operating expenses, while progressing its US growth strategy with a major California acquisition.

Ramsay Health Care is set to simplify its corporate structure by distributing its majority stake in European healthcare provider Ramsay Santé directly to shareholders, enabling focused growth strategies for both entities.

Guzman y Gomez has reported a robust first half of FY26, delivering strong revenue and profit growth alongside significant restaurant network expansion in Australia and the US.

Reef Casino Trust has reported a 4.8% increase in revenue and a 6.4% rise in net profit for 2025, supported by strong casino and hotel performance. Meanwhile, a takeover bid at $3.87 per unit is underway, backed by major unitholders and recommended by the board.

BTC Health reports a slight statutory loss in HY26 amid a 7% revenue dip, offset by strong growth in its cardio segment driven by key hospital contracts.

Terragen Holdings reports a 23% reduction in half-year net loss amid strategic shifts and completes a $7 million equity raise to accelerate global commercialisation of its biological agricultural products.

Motio Limited has reported its first-ever net profit alongside a 39% surge in cash EBITDA, underpinned by strategic cost discipline and a strengthened balance sheet. The company is now poised to accelerate network growth, particularly in the health sector.

Ashley Services Group has reported a robust first half for 2026, with significant growth in earnings and dividends, underpinned by strong labour hire and training divisions.

Cyclopharm Limited is rapidly scaling its US presence for Technegas®, securing new contracts across federal institutions and major health networks in four key regions. The company aims for up to 300 installations by late 2026, boosting recurring revenue streams.

Austral Resources Australia Ltd has resumed trading on the ASX following news of a significant capital raising and a strategic investor commitment, signaling renewed confidence in the company’s future.